Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions
Jindi Huang, Liye Chen, Jiangxia Wu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16033-16061
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 38
Retinal Microenvironment‐Protected Rhein‐GFFYE Nanofibers Attenuate Retinal Ischemia‐Reperfusion Injury via Inhibiting Oxidative Stress and Regulating Microglial/Macrophage M1/M2 Polarization
Zhuhong Zhang, Shengjun Peng, Tengyan Xu, et al.
Advanced Science (2023) Vol. 10, Iss. 30
Open Access | Times Cited: 34
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 16
Design and synthesis of phenylthiophosphoryl dichloride derivatives and evaluation of their antitumour and anti-inflammatory activities
Chunyun Xu, Na Yang, Hsiao‐Wei Yu, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access | Times Cited: 1
Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
Lu Jin, Yinghui Guan, Xue Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1083-1103
Open Access | Times Cited: 1
A novel integrative multimodal classifier to enhance the diagnosis of Parkinson’s disease
Xiaoyan Zhou, Luca Parisi, Wentao Huang, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access | Times Cited: 1
Biomarkers for Early Detection of Cancer: Molecular Aspects
Paramjit S. Tappia, Bram Ramjiawan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5272-5272
Open Access | Times Cited: 17
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer
Katerina Kitsios, Shahriar Sharifi, Morteza Mahmoudi
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 5, pp. 671-682
Open Access | Times Cited: 17
PI3Kδ and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analogues
Digambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107323-107323
Closed Access | Times Cited: 8
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy
Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116698-116698
Closed Access | Times Cited: 8
Selectivity Studies and Free Energy Calculations of AKT Inhibitors
Haizhen A. Zhong, David T. Goodwin
Molecules (2024) Vol. 29, Iss. 6, pp. 1233-1233
Open Access | Times Cited: 7
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 3, pp. 141-158
Closed Access | Times Cited: 7
Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
Xiaofei Cheng, Feng Zhao, Bingxin Ke, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5209-5209
Open Access | Times Cited: 16
Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 14
Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer
Qiwen Sun, Yuxiu Chu, Nana Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7330-7358
Closed Access | Times Cited: 5
A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms
Peng Zhang, Wu Luo, Zixin Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 5
Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking
Jingyu Zhu, Huiqin Meng, Xintong Li, et al.
Computational Biology and Chemistry (2024) Vol. 109, pp. 108011-108011
Closed Access | Times Cited: 4
Histone deacetylase 6 deficiency protects the liver against ischemia/reperfusion injury by activating PI3K/AKT/mTOR signaling
Jie Pan, Q C Yu, Yaodong Song, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 4
Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway
Xin Wang, Hui Liu, Yuqi Wang, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1422-1430
Closed Access | Times Cited: 4
Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner
Sudha Singh, Cody A. Braun, Amanda Carroll‐Portillo, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1833-1833
Open Access | Times Cited: 4
·Role of Cathepsin K in Bone Invasion of Pituitary Adenomas: A Dual Mechanism Involving Cell Proliferation and Osteoclastogenesis
Hongyan Liu, Peng Wang, Jiakui Li, et al.
Cancer Letters (2025) Vol. 611, pp. 217443-217443
Open Access
Exploring the Mechanism of Sishen Decoction in Intervening Diarrhea-Predominant Irritable Bowel Syndrome with Depression Based on Network Pharmacology
小萍 谢
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 622-633
Closed Access
In vitro and in silico hybrid approach to unveil triterpenoids from Helicteres hirsuta leaves as potential compounds for inhibiting Nrf2
Hien Minh Nguyen, Nguyen Thien Han Le, Bui Quoc Huy Nguyen, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1915-1923
Open Access
Serum Pharmacochemistry and Network Pharmacology Reveal Active Compounds and Mechanisms of the Huaxian Formula in Alleviating Radiation-Induced Pulmonary Fibrosis
Caiping Gong, Junyang Chen, Pingjin Zou, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 627-644
Open Access
Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes
Munier Hossain, Md. Arafat Hossain
European Journal of Pharmacology (2025), pp. 177432-177432
Closed Access
Page 1 - Next Page

Scroll to top